N/A
N=1,170
A Message Framing Intervention for Increasing Parental Acceptance of Human Papillomavirus Vaccination
Cervical Cancer · Anal Cancer · Penile Cancer
Bottom Line
View on ClinicalTrials.gov: NCT03856437 ↗Enrolled (actual)
1,170
Serious AEs
—
Results posted
Mar 2024
Primary outcome: Primary: Attitudes — 5.61; 5.56; 5.51 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- HPV vaccination messages (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Maryland, College Park
- Primary completion
- Mar 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Attitudes |
5.61; 5.56; 5.51 | — |
| PRIMARY Intention to Vaccinate Free of Cost |
4.56; 4.59; 4.46 | — |
| SECONDARY Intention to Vaccinate With Cost |
4.17; 4.27; 4.08 | — |
Summary
The goal of this study is to determine the effects of message framing (gain vs. loss) on African American parents' acceptance of the HPV vaccine and how such effects are moderated by parents' salient beliefs prior to message exposure. Participants are randomized into gain and loss conditions in which they view either gain-framed or loss-framed HPV vaccination messages. Key outcome variables include parents' attitudes and intentions toward vaccinating their children against HPV.
Eligibility Criteria
Inclusion Criteria
- 18 years or older
- Self-identify as African American
- Custodial parent or caretaker of at least one child under the age of 18 who has not been fully vaccinated against HPV.
- Has access to Internet to complete the study
Exclusion Criteria
- Younger than 18 years
- Does not self-identify as African American
- Not a custodial parent or caretaker of at least one child under the age of 18 who has not been fully vaccinated against HPV.
- Has no access to Internet to complete the study
Data sourced from ClinicalTrials.gov (NCT03856437). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.